Thus, ACE2 plays a critical role in cardiopulmonary homeostasis through its vasoprotective function, and the ACE2/Ang-(1–7)/Mas 1 receptor signaling pathway is anticipated to be a promising therapeutic target for PAH (Papavassiliou et al., 2023). Here, ACE2 is linked to pulmonary arterial hypertension.